Covered recipient · General Payments record
KI EUM
General Payments · PY2020–2022
$1,038.90
- Reported across 33 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $543.87 | 14 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $230.39 | 6 |
| ABBVIE INC. | $145.84 | 2 |
| Aurinia Pharma U.S., Inc. | $71.22 | 2 |
| Ferring Pharmaceuticals Inc. | $30.59 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.68 | 1 |
| Acerta Pharma LLC | $20.92 | 1 |
| Hikma Pharmaceuticals USA | $17.23 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (14)
Sorted by paying entity, then date · as published by CMS
Program year 2022 20202021
Record-level detail is published for PY2022; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $120.58 | 02/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894935907 | CMS |
| ABBVIE INC. | $25.26 | 03/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | 894943101 | CMS |
| Amgen Inc. | $31.11 | 01/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939424633 | CMS |
| Amgen Inc. | $28.43 | 02/01/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939424637 | CMS |
| Amgen Inc. | $5.20 | 03/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939424639 | CMS |
| Amgen Inc. | $26.10 | 04/12/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939424641 | CMS |
| Amgen Inc. | $29.55 | 06/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939424635 | CMS |
| Amgen Inc. | $110.00 | 10/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | 965589463 | CMS |
| AstraZeneca Pharmaceuticals LP | $20.92 | 03/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 920242135 | CMS |
| Aurinia Pharma U.S., Inc. | $20.91 | 01/18/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954075277 | CMS |
| Aurinia Pharma U.S., Inc. | $50.31 | 02/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 954075281 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $27.68 | 01/11/2022 | Food and Beverage | Undisputed | 01/23/2026 | 887740301 | CMS |
| Ferring Pharmaceuticals Inc. | $30.59 | 02/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 875348321 | CMS |
| Hikma Pharmaceuticals USA | $17.23 | 03/15/2022 | Food and Beverage | Undisputed | 01/23/2026 | 927074441 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022
- Source files
- Dataset page · Bulk file · PY2020 , PY2021 , PY2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.